COPD Flashcards
what type of inhalers do you shake before use
MDI
SABA/SAMA use in COPD
“rescue” with occasional symptoms or on maintenance therapy
solo SAMA/SABA or SAMA+SABA
SABA+SAMA is more effective than either drug alone
ipratropium
SAMA - usually combined with albuterol for COPD + bronchospasm in the hospital
SAMA ADRs
dry mouth, pharyngeal irritation
best drug to prevent exacerbations in pts with mod-very severe COPD
LAMA > LABA
tiotropium
LAMA (QD)
umeclidinium
LAMA (QD)
revefenacin
LAMA (QD)
aclidinium
LAMA (BID)
glycopyrrolate
LAMA (BID)
list of LAMAs for COPD
tiotropium (QD) umeclidinium (QD) revefenacin (QD) aclidinium (BID) glycopyrrolate (BID) (- ium and -late)
list of LABAs for COPD
indacaterol (QD) olodaterol (QD) salmeterol (BID) formoterol (BID) arformoterol (BID) (-terols)
interactions of B-blockers + LABAs
historically were contraindicated; now are shown to decrease mortality & exacerbations
when would you use dual bronchodilator therapy with LAMA + LABA
moderate-severe dyspnea/symptoms & at risk for exacerbations & for those with persistent symptoms/exacerbations despite use of long-acting bronchodilator
steps of what inhalers you would give COPD patient
SABA –> LAMA –> LAMA+LABA (and still SABA, always)
when would you do an ICS/LABA combo
moderate-severe COPD who experience frequent exacerbations while on > 2 long-acting agents (LABA + LAMA)
or pts with mixed asthma - COPD phenotypes
ADRs of ICS
dysphonia, OP candidiasis, glaucoma, increased risk of thrush, more pneuomonia cases, increased risk of fracture
roflumilast MOA
selective inhibitor of PDE4 = increased intracellular [cAMP] = decreased inflammation
roflumilast indications
severe COPD associated with chronic bronchitis & history of AE-COPD
roflumilast ADRs
N/V/D, weight loss, insomnia, anxiety/depression
theophylline indications
pts with persistent symptoms despite tx with inhaled triple-therapy
GOLD group A treatment
SABA alone
GOLD group B treatment
SABA + LAMA
GOLD group C treatment
ensure on at least long-acting dilator (LAMA>LABA)
2 long acting bronchodilators
reserve ICS for severe disease or pts with asthma
GOLD group D treatment
ensure on 2 long acting meds, reserve ICS
managed by pulmonologist probably
why wouldn’t you want to give a pt a LAMA + ipratropium
both are muscarinic antagonists = more ADRs
use SABA + LAMA instead